Fidelix accused of fabricating ₩15.1B in sales
Predicted impact: Medium
Fabricated sales of ₩15.1B (about 18% of last year's revenue) already covered by prosecution referral and trading halt news.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.